- Q4 2023 Immunocore Holdings PLC Earnings Call TranscriptFeb 28, 2024$69.21 (-1.76%)Earnings
- Immunocore Holdings PLC at JPMorgan Healthcare Conference TranscriptJan 10, 2024
- Immunocore Holdings PLC at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2023
- Q2 2023 Immunocore Holdings PLC Earnings Call TranscriptAug 10, 2023$61.66 (-3.67%)Earnings
- Immunocore Holdings PLC at Goldman Sachs Healthcare Conference TranscriptJun 14, 2023
- Immunocore Holdings PLC at Bank of America Global Healthcare Conference TranscriptMay 11, 2023
- Immunocore Holdings PLC at Barclays Global Healthcare Conference TranscriptMar 15, 2023
- Q4 2022 Immunocore Holdings PLC Earnings Call TranscriptMar 01, 2023$54.05 (-1.46%)Earnings
- Immunocore Holdings PLC at Citi Virtual Oncology Leadership Summit TranscriptFeb 22, 2023
- Immunocore Holdings PLC at JPMorgan Healthcare Conference TranscriptJan 11, 2023
- Immunocore Holdings PLC at Evercore ISI HealthCONx Conference (Virtual) TranscriptNov 30, 2022
- Immunocore Holdings PLC at Jefferies London Healthcare Conference TranscriptNov 17, 2022
- Immunocore Holdings PLC PRAME Investor and Analyst Event AT ESMO 2022 TranscriptSep 09, 2022
- Q2 2022 Immunocore Holdings PLC Earnings Call TranscriptAug 10, 2022$53.95 (+4.27%)Earnings
- Immunocore Holdings PLC at Needham Healthcare Conference (Virtual) TranscriptApr 14, 2022
- Immunocore Holdings PLC To Discuss FDA Approval Call TranscriptJan 26, 2022
Immunocore Holdings PLC at JPMorgan Healthcare Conference Transcript
Good morning, everyone. My name is Jess Fye. I'm a senior biotech analyst at JP Morgan, and we're continuing the 42' Annual Healthcare Conference today with Immunocore. I'm joined on stage by the company's CEO, Bahija Jallal. She's going to give a presentation on the business, and then we're going to go into Q&A. (Operator Instructions) So with that, let me pass it over to Bahija.
&
All right. Good morning, everyone. Thank you, Jess, for having us. I would like to start with a patient story. A few days ago, we met this very vibrant CEO. She was diagnosed seven years before with uveal melanoma, metastatic uveal melanoma. Her doctor said, only a few months to your daughter's graduation, but actually, you're not going to make it to that graduation. She enrolled into KIMMTRAK, and she lived seven years to tell her story. This is always what reminds me why we come to work every day, and what a privilege to be doing what we do.
So let's
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)